3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Metabolic Syndrome
1
Lymphoma, Non-Hodgkin
1
Heart Failure
1
Dyslipidemias
1
Central Nervous System Neoplasms
1
Cardiovascular Diseases
1
Cardiotoxicity
1
Cardiomyopathies
1
Interventions
Echocardiography
11
Electrocardiography
5
Trastuzumab
4
Social Determinants of Health
2
Doxorubicin
2
Chemoradiotherapy
2
Blood Specimen Collection
2
Antineoplastic Agents
2
Vascular Stiffness
1
Standard of Care
1
Resistance Training
1
Pulse Wave Analysis
1
Positron Emission Tomography Computed Tomography
1
Magnetic Resonance Spectroscopy
1
Immunomodulating Agents
1
Hematologic Tests
1
Gonadal Steroid Hormones
1
Exercise Test
1
EGFR tyrosine kinase inhibitor 324674
1
Clinical Laboratory Techniques
1
Cisplatin
1
Cardiography, Impedance
1
Anthracyclines
1
Amplified Fragment Length Polymorphism Analysis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Cardiotoxicity
×
Pulse Wave Analysis
×
Clear all
NCT07041827
2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
217 enrolled